In conclusion, our theoretical calculations strongly indicate that 513457 holds great promise as a potential CCND1-CDK4 PPI inhibitor, capable of effectively replacing P21 and significantly limiting tumor cell proliferation, particularly in scenarios with lower P21 levels. This evidence concerns the gene CDK4 and neoplasm.